litlas
Log inCreate account

Stephen A. Boorjian

Active 2004–2025

207
Papers
26,718
Citations
97
h-index
195
i10-index

Citations

Citations per year for Stephen A. Boorjian1982: 1 citations1993: 1 citations1997: 1 citations2000: 1 citations2001: 1 citations2002: 2 citations2003: 1 citations2004: 2 citations2005: 3 citations2006: 11 citations2007: 17 citations2008: 40 citations2009: 47 citations2010: 58 citations2011: 100 citations2012: 121 citations2013: 125 citations2014: 117 citations2015: 158 citations2016: 178 citations2017: 146 citations2018: 182 citations2019: 728 citations2020: 935 citations2021: 801 citations2022: 627 citations2023: 532 citations2024: 1,001 citations2025: 404 citations2026: 17 citations1983–1992: no citations, so these years are not shown1994–1996: no citations, so these years are not shown1998–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,311 citing papers, 23.6% of this breakdownChina: 1,035 citing papers, 10.6% of this breakdownItaly: 719 citing papers, 7.3% of this breakdownGermany: 524 citing papers, 5.3% of this breakdownUnited Kingdom: 512 citing papers, 5.2% of this breakdownCanada: 487 citing papers, 5% of this breakdownFrance: 407 citing papers, 4.2% of this breakdownJapan: 335 citing papers, 3.4% of this breakdownNetherlands: 315 citing papers, 3.2% of this breakdownAustria: 281 citing papers, 2.9% of this breakdownSpain: 278 citing papers, 2.8% of this breakdownSwitzerland: 190 citing papers, 1.9% of this breakdown
0%23.6%Other 24.6%

Institutions

Fields

  • Medicine83.5%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Immunology and Microbiology1.8%
  • Health Professions0.6%
  • Engineering0.6%
  • Computer Science0.5%
  • Other1.9%

Topics

  • Bladder and Urothelial Cancer Treatments13%
  • Renal cell carcinoma treatment8.7%
  • Urinary and Genital Oncology Studies5.9%
  • Prostate Cancer Diagnosis and Treatment4.8%
  • Prostate Cancer Treatment and Research4.4%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Other60.3%

Coauthors

All papers

Open in search
  1. Epidemiology of Renal Cell Carcinoma

    Authors: Umberto Capitanio, Karim Bensalah, Axel Bex, Stephen A. Boorjian, Freddie Bray, Jonathan Coleman, John L. Gore, Maxine Sun, Christopher G. Wood, Paul Russo - European Urology 2018 cited by 1,655

  2. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

    Authors: Sam S. Chang, Stephen A. Boorjian, Roger Chou, Peter E. Clark, Siamak Daneshmand, Badrinath R. Konety, Raj S. Pruthi, Diane Zipursky Quale, Chad R. Ritch, John D. Seigne, Eila C. Skinner, Norm D. Smith, James M. McKiernan - The Journal of Urology 2016 cited by 1,385

  3. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

    Authors: Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne Schuckman, Tracy M. Downs, Robert S. Svatek, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael Woods, Gordon Brown, Daniel Canter, Adam Luchey, Yair Lotan, Tracey L. Krupski, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Kirk A. Keegan, Gerald L. Andriole, Alexander I. Sankin, Alan Boyd, Michael A. O’Donnell, David G. Sawutz, Richard Philipson, Ruth Coll, Vikram M. Narayan, F. Peter Treasure, Seppo Ylä‐Herttuala, Nigel Parker, Colin P. Dinney - The Lancet Oncology 2020 cited by 442

  4. NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

    Authors: Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 cited by 302

  5. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

    Authors: James A. Eastham, Gregory B. Auffenberg, Daniel A. Barocas, Roger Chou, Tony Crispino, John W. Davis, Scott E. Eggener, Eric M. Horwitz, Christopher J. Kane, Erin Kirkby, Daniel W. Lin, Sean M. McBride, Alicia K. Morgans, Phillip M. Pierorazio, George Rodrigues, William W. Wong, Stephen A. Boorjian - The Journal of Urology 2022 cited by 441

  6. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

    Authors: Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam S. Chang, Tracy M. Downs, Jason A. Efstathiou, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman‐Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker‐Radtke, Jonathan D. Tward, Jonathan L. Wright, Lisa A. Gurski, Alyse Johnson-Chilla - Journal of the National Comprehensive Cancer Network 2020 cited by 628

  7. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

    Authors: James A. Eastham, Gregory B. Auffenberg, Daniel A. Barocas, Roger Chou, Tony Crispino, John W. Davis, Scott E. Eggener, Eric M. Horwitz, Christopher J. Kane, Erin Kirkby, Daniel W. Lin, Sean M. McBride, Alicia K. Morgans, Phillip M. Pierorazio, George Rodrigues, William W. Wong, Stephen A. Boorjian - The Journal of Urology 2022 cited by 250

  8. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

    Authors: Jakub Dobruch, Siamak Daneshmand, Margit Fisch, Yair Lotan, Aidan P. Noon, Matthew J. Resnick, Shahrokh F. Shariat, Alexandre R. Zlotta, Stephen A. Boorjian - European Urology 2015 cited by 683

  9. 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19

    Authors: Niyati Lobo, Nathan A. Brooks, Alexandre R. Zlotta, Jeffrey D. Cirillo, Stephen A. Boorjian, Peter C. Black, Joshua J. Meeks, Trinity J. Bivalacqua, Paolo Gontero, Gary D. Steinberg, David J. McConkey, Marko Babjuk, J. Alfred Witjes, Ashish M. Kamat - Nature Reviews Urology 2021 cited by 147

  10. Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

    Authors: Bradley C. Leibovich, Christine M. Lohse, Paul L. Crispen, Stephen A. Boorjian, R. Houston Thompson, Michael L. Blute, John C. Cheville - The Journal of Urology 2010 cited by 460

  11. First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer

    Authors: Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Huan He, Noureen Asghar, Rabbia Siddiqi, Hongfang Liu, Parminder Singh, Daniel S. Childs, Praful Ravi, Syed A. Hussain, M. Hassan Murad, Stephen A. Boorjian, Christopher J. Sweeney, Eliezer M. Van Allen, Alan H. Bryce - JAMA Oncology 2023 cited by 121

  12. The Microbiome and Genitourinary Cancer: A Collaborative Review

    Authors: Mark C. Markowski, Stephen A. Boorjian, Jeremy P. Burton, Noah M. Hahn, Molly A. Ingersoll, Saman Maleki Vareki, Sumanta K. Pal, Karen S. Sfanos - European Urology 2019 cited by 176

  13. Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

    Authors: Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, R. Houston Thompson, Stephen A. Boorjian, Haidong Dong, Bradley C. Leibovich, Michael L. Blute, Eugene D. Kwon - Clinical Cancer Research 2008 cited by 272

  14. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery

    Authors: Bradley C. Leibovich, Christine M. Lohse, John C. Cheville, Harras B. Zaid, Stephen A. Boorjian, Igor Frank, R. Houston Thompson, William P. Parker - European Urology 2018 cited by 229

  15. Microhematuria: AUA/SUFU Guideline

    Authors: Daniel A. Barocas, Stephen A. Boorjian, Ronald D. Alvarez, Tracy M. Downs, Cary P. Gross, Blake D. Hamilton, Kathleen C. Kobashi, Robert R. Lipman, Yair Lotan, Casey K. Ng, Matthew E. Nielsen, Andrew C. Peterson, Jay D. Raman, Rebecca Smith-Bindman, Lesley H. Souter - The Journal of Urology 2020 cited by 241

  16. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy

    Authors: Siamak Daneshmand, Clint Cary, Timothy A. Masterson, Lawrence H. Einhorn, Nabil Adra, Stephen A. Boorjian, Christian Kollmannsberger, Anne Schuckman, Alan So, Peter C. Black, Aditya Bagrodia, Eila C. Skinner, Mehrdad Alemozaffar, Timothy C. Brand, Scott E. Eggener, Phillip M. Pierorazio, Kelly Stratton, Lucia Nappi, Craig R. Nichols, Chunqiao Luo, Ming Li, Brian Hu - Journal of Clinical Oncology 2023 cited by 103

  17. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline

    Authors: James A. Eastham, Stephen A. Boorjian, Erin Kirkby - The Journal of Urology 2022 cited by 91

  18. Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

    Authors: Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne Schuckman, Tracy M. Downs, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael Woods, Gordon Brown, Daniel Canter, Adam Luchey, Yair Lotan, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Sam S. Chang, Alexander I. Sankin, Michael A. O’Donnell, David G. Sawutz, Richard Philipson, Nigel Parker, Seppo Ylä‐Herttuala, Dorte Rehm, Jørn S. Jakobsen, Kristian Vinter Juul, Colin P. Dinney - The Journal of Urology 2024 cited by 75

  19. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials

    Authors: Pramit Khetrapal, Joanna Wong, Wei Phin Tan, Thiara Rupasinghe, Wei Shen Tan, Stephen B. Williams, Stephen A. Boorjian, Carl Wijburg, Dipen J. Parekh, Peter Wiklund, Nikhil Vasdev, Muhammad Shamim Khan, Khurshid A. Guru, James W.F. Catto, John D. Kelly - European Urology 2023 cited by 103

  20. Efficiency, Satisfaction, and Costs for Remote Video Visits Following Radical Prostatectomy: A Randomized Controlled Trial

    Authors: Boyd R. Viers, Deborah J. Lightner, Marcelino Rivera, Matthew K. Tollefson, Stephen A. Boorjian, R. Jeffrey Karnes, R. Houston Thompson, Daniel A. O’Neil, Rachel L Hamilton, Matthew R. Gardner, Mary Bundrick, Sarah M. Jenkins, Sandhya Pruthi, Igor Frank, Matthew T. Gettman - European Urology 2015 cited by 255

  21. Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study

    Authors: Neal D. Shore, Stephen A. Boorjian, Daniel Canter, Kenneth Ogan, Lawrence I. Karsh, Tracy M. Downs, Leonard G. Gomella, Ashish M. Kamat, Yair Lotan, Robert S. Svatek, Trinity J. Bivalacqua, Robert L. Grubb, Tracey L. Krupski, Seth P. Lerner, Michael Woods, Brant A. Inman, Matthew I. Milowsky, Alan Boyd, F. Peter Treasure, Gillian Gregory, David G. Sawutz, Seppo Ylä‐Herttuala, Nigel Parker, Colin P. Dinney - Journal of Clinical Oncology 2017 cited by 172

  22. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality

    Authors: Sarah P. Psutka, Alonso Carrasco, Grant D. Schmit, Michael R. Moynagh, Stephen A. Boorjian, Igor Frank, Suzanne Stewart, Prabin Thapa, Robert F. Tarrell, John C. Cheville, Matthew K. Tollefson - Cancer 2014 cited by 295

  23. Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma

    Authors: Niraj Shenoy, Tushar D. Bhagat, John C. Cheville, Christine M. Lohse, Sanchari Bhattacharyya, Alexander Tischer, Venkata R. Machha, Shanisha Gordon-Mitchell, Gaurav S. Choudhary, Li-Fan Wong, LouAnn Gross, Emily Ressigue, Bradley C. Leibovich, Stephen A. Boorjian, Ulrich Steidl, Xiaosheng Wu, Kith Pradhan, Benjamin A. Gartrell, Beamon Agarwal, Lance C. Pagliaro, Masako Suzuki, John M. Greally, Dinesh Rakheja, R. Houston Thompson, Katalin Suszták, Thomas E. Witzig, Yiyu Zou, Amit Verma - Journal of Clinical Investigation 2019 cited by 111

  24. Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

    Authors: Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo, Edouard J. Trabulsi, Eric A. Ross, Richard E. Greenberg, David Y.T. Chen, Costas D. Lallas, Yu-Ning Wong, Jianqing Lin, Alexander Kutikov, Efrat Dotan, Timothy Brennan, Norma Alonzo Palma, Essel Dulaimi, Reza Mehrazin, Stephen A. Boorjian, William Kevin Kelly, Robert G. Uzzo, Gary R. Hudes - Journal of Clinical Oncology 2014 cited by 281